Showing results (951-960 of 3,524) with videos related to

Sort By:
Pageof 353
Thoracic Cancer|November 30, 2022
RIG-I-mediated innate immune signaling in tumors reduces the therapeutic effect of oncolytic vesicular stomatitis virusPengfei Zhang, Xinyu Han, Weiqi Tan, et al.
Thoracic Cancer|November 30, 2022
Incidental diagnosis of pulmonary cryptococcosis by rebiopsy for epidermal growth factor receptor T790M mutation: A case reportHiroshi Kobe, Shinya Yokoe, Tadashi Ishida
Thoracic Cancer|November 30, 2022
Feasibility and safety of secondary video-assisted thoracoscopic surgery for ipsilateral lung cancer after prior pulmonary resectionLei Chen, Zhenyu Yang, Ruichen Cui, et al.
Thoracic Cancer|June 24, 2022
Pulmonary mucoepidermoid carcinoma: A clinicopathological study of 45 patientsWang Shen, Tao Yang, Yaguang Fan, et al.
Thoracic Cancer|November 25, 2022
Epidermal growth factor receptor tyrosine kinase inhibitors for non-small cell lung cancer harboring uncommon EGFR mutations: Real-world data from TaiwanJohn Wen-Cheng Chang, Chen-Yang Huang, Yueh-Fu Fang, et al.
Thoracic Cancer|November 25, 2022
"Separated" precise subsegmentectomy: Single-port thoracoscopic noncombined subsegmentectomy in one lung lobeShuliang Zhang, Maohui Chen, Yizhou Huang, et al.
Thoracic Cancer|July 9, 2022
Association of thyroid transcription factor-1 with the efficacy of immune-checkpoint inhibitors in patients with advanced lung adenocarcinomaKenji Nakahama, Hiroyasu Kaneda, Masahiko Osawa, et al.
Thoracic Cancer|July 11, 2022
99m Tc bone scintigraphy does not affect preoperative workup for patients with potentially resectable esophageal squamous cell carcinomaXiu-Feng Wei, Xian-Kai Chen, Lu Lu, et al.
Thoracic Cancer|July 12, 2022
Non-small cell lung cancer with tumor proportion score > 90% could increase the risk of severe immune-related adverse events in first-line treatments with immune checkpoint inhibitors: A retrospective single-center studyYuki Akazawa, Aki Yoshikawa, Masaki Kanazu, et al.
Thoracic Cancer|May 20, 2019
Prognostic value of a novel scoring system using inflammatory response biomarkers in non-small cell lung cancer: A retrospective studyYan Wang, Xu Hu, Wenying Xu, et al.
Pageof 353